Ultragenyx Pharmaceutical (RARE) Enterprise Value Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Ultragenyx Pharmaceutical | 2.29 Bn | 1.89 Bn | 106.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.91% |
| Dec 31, 2025 | 10.95% |
| Sep 30, 2025 | 11.39% |
| Jun 30, 2025 | -7.44% |
| Mar 31, 2025 | 5.98% |
| Dec 31, 2024 | 4.40% |
| Sep 30, 2024 | -3.12% |
| Jun 30, 2024 | -4.32% |
| Mar 31, 2024 | 10.44% |
| Dec 31, 2023 | -4.67% |
| Sep 30, 2023 | 2.55% |
| Jun 30, 2023 | -0.18% |
| Mar 31, 2023 | -3.06% |
| Dec 31, 2022 | -26.10% |
| Sep 30, 2022 | -19.09% |
| Jun 30, 2022 | -6.31% |
| Mar 31, 2022 | -7.07% |
| Dec 31, 2021 | -14.26% |
| Sep 30, 2021 | -13.21% |
| Jun 30, 2021 | -16.64% |
| Mar 31, 2021 | -18.58% |
| Dec 31, 2020 | -22.42% |
| Sep 30, 2020 | -11.29% |
| Jun 30, 2020 | -0.58% |
| Mar 31, 2020 | -14.13% |
| Dec 31, 2019 | -32.14% |
| Sep 30, 2019 | -21.24% |
| Jun 30, 2019 | -32.17% |
| Mar 31, 2019 | -34.03% |
| Dec 31, 2018 | -186.63% |
| Sep 30, 2018 | -142.10% |
| Jun 30, 2018 | -109.66% |
| Mar 31, 2018 | -52.89% |